LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 17.28 | 27.76 | 62 | 838 | 0.0739 | 0.1775 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 17.28 | 27.76 | 1187 | 838 | 1.4153 | 1.1464 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 18.98 | 27.76 | 723 | 941 | 0.7682 | 0.8989 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 18.98 | 27.76 | 1047 | 941 | 1.1125 | 1.0424 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 18.98 | 27.76 | 68 | 941 | 0.0723 | 0.1927 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 18.98 | 27.76 | 1059 | 941 | 1.1252 | 1.0470 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 20.68 | 27.76 | 883 | 1119 | 0.7891 | 0.9131 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 20.68 | 27.76 | 1049 | 1119 | 0.9374 | 0.9759 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 20.68 | 27.76 | 72 | 1119 | 0.0643 | 0.1957 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 20.68 | 27.76 | 1168 | 1119 | 1.0438 | 1.0161 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 22.39 | 27.76 | 958 | 1305 | 0.7337 | 0.8916 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 22.39 | 27.76 | 1071 | 1305 | 0.8202 | 0.9299 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 22.39 | 27.76 | 87 | 1305 | 0.0666 | 0.2283 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 22.39 | 27.76 | 931 | 1305 | 0.7130 | 0.8819 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.09 | 27.76 | 980 | 1461 | 0.6705 | 0.8650 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.09 | 27.76 | 1064 | 1461 | 0.7280 | 0.8920 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.09 | 27.76 | 91 | 1461 | 0.0623 | 0.2308 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.09 | 27.76 | 859 | 1461 | 0.5877 | 0.8225 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 25.79 | 27.76 | 994 | 1605 | 0.6193 | 0.8428 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 25.79 | 27.76 | 1064 | 1605 | 0.6629 | 0.8643 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 25.79 | 27.76 | 105 | 1605 | 0.0654 | 0.2552 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 25.79 | 27.76 | 988 | 1605 | 0.6155 | 0.8409 | MN20160318_Q01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 27.49 | 27.76 | 990 | 1723 | 0.5745 | 0.8223 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 27.49 | 27.76 | 1055 | 1723 | 0.6123 | 0.8419 | MN20160318_Q01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 27.49 | 27.76 | 126 | 1723 | 0.0731 | 0.2892 | MN20160318_Q01 | M14 |